Could manufacturers using UK notified bodies have post-Brexit difficulties?

There is some apprehension among manufacturers who have used one of the UK’s notified bodies to appraise the conformity of their medtech products against the medical device directives about the effects of Brexit on their products’ continued existence on the market, as well as on their businesses.

contact us for further information

Posted on 20. Februar 2018
↑ back to top
picture kazurabashi vine bridge

Many bad traps are hidden
in the EU regulatory jungle
We guide you safely

mdi Europa facebook profile mdi Europa linkedin profile

News in Brief

.

grafik CE mark